India Adult Vaccine Market: Addressing Low Urban Vaccination Rates (2%-5%) Despite the Nation Producing 60% of Global Vaccines

India's position as a global leader in vaccine production is undeniable, manufacturing approximately 60% of the world's vaccines as of 2023. Despite this leadership, the country faces significant challenges in adult vaccination coverage, particularly in urban populations. With 16.2% of the adult population classified as elderly, only 2%-5% of urban adults receive vaccinations, highlighting the critical need for improved access and awareness in adult immunization programs.

For more details:
India Adult Vaccine Market Report - Global Vaccination Coverage, Demand, Opportunities, Pipeline Vaccines, and Competitive Analysis
https://www.makreo.com/report/india-adult-vaccine-market-report-global-vaccination-coverage-demand-opportunities-pipeline-vaccines-and-competitive-analysis

► Diverse Adoption Across APAC and the Impact on the India Adult Vaccine Market
In the Asia-Pacific (APAC) region, the adult vaccine market is influenced by factors such as the ongoing battle against seasonal influenza, the prevalence of hepatitis, and the rising demand for HPV vaccines in cancer prevention. COVID-19 vaccines continue to play a vital role, particularly with booster doses. However, regional disparities in healthcare infrastructure and public health policies result in uneven vaccine coverage, especially in developing nations.

East Asian countries like Japan and South Korea have established adult vaccination programs with high coverage rates, while Southeast Asia shows varied adoption rates, with Singapore and Thailand leading regional efforts. South Asian countries, including India and Pakistan, are gradually improving vaccine coverage despite challenges related to healthcare infrastructure and public awareness.

► Cervical Cancer Prevention in the India Adult Vaccine Market
Among India's most pressing public health concerns is cervical cancer, a preventable disease that claims the life of one Indian woman every seven minutes. Accounting for 21% of global cervical cancer deaths, this disease remains the second most common cancer among Indian women, with approximately 125,000 new cases and 75,000 deaths annually. The high cost of HPV vaccines, often priced at INR 4,000 per dose, has made prevention inaccessible for many, particularly in low- and middle-income groups.

► India Adult Vaccine Market Challenges and Growth Drivers
Despite these challenges, India's adult vaccine market shows significant potential, driven by the growing demand for vaccines such as influenza, pneumococcal, hepatitis, and COVID-19. However, several barriers hinder broader vaccine uptake:

1. Low Investment in Adult Vaccines: Less than 2% of pharmaceutical expenditure is allocated to adult vaccines in most regions, reflecting a lack of prioritization.
2. Post-Pandemic Recovery: While adult vaccination peaked during the COVID-19 pandemic, rates have not yet returned to pre-pandemic levels.
3. Vaccine Hesitancy: Misinformation and low awareness contribute to vaccine hesitancy among adults.
4. Operational Challenges: Issues like vaccine delivery, limited access points, and complex vaccination schedules pose barriers to adult immunization programs.

► Key Players in the Indian Vaccine Market
The report provides an extensive analysis of major players driving vaccine production and innovation in India. Key companies include Merck Group, Pfizer Ltd., Sanofi Pasteur, Serum Institute of India, and Bharat Biotech, all of which continue to lead domestic and global vaccine development efforts.

► Government Initiatives and Future Innovations
The Universal Immunization Program (UIP) remains a cornerstone of India's vaccination efforts. However, the report emphasizes the need for increased government support for adult vaccines, particularly in research and development. As India continues to expand its vaccine production capacity, the report anticipates further breakthroughs in vaccine technology and infrastructure to address public health challenges.

► India Adult Vaccine Market Opportunities and Innovations
The future of India's adult vaccine market is set for significant growth, driven by promising pipeline vaccines and technological advancements. The Indian government's commitment to fostering innovation in vaccine research, coupled with rising awareness of the importance of adult vaccination, is expected to create new opportunities for both domestic and international players in the market.

Makreo Research is pleased to present a comprehensive report titled "India Adult Vaccine Market Report - Global Vaccination Coverage, Demand, Opportunities, Pipeline Vaccines, and Competitive Analysis." This detailed analysis investigates how India's diverse economic, geographic, and healthcare landscapes influence market dynamics.

The report provides an in-depth evaluation of both historical and current market performance, focusing on various segments, including disease types and vaccine categories. Key demand drivers are explored, alongside critical end-user sectors such as healthcare facilities and vaccination programs. The report assesses the effectiveness of various vaccines in addressing public health challenges and reviews relevant government policies and regulations that shape the India Adult Vaccine Market, offering insights into their impact on growth and development.

Additionally, the report features a comprehensive analysis of major players in the India Adult Vaccine Market, highlighting prominent companies like Merck Group, Pfizer Ltd., Sanofi Pasteur, Serum Institute of India, and Bharat Biotech. It provides insights into their recent developments, innovations, and detailed company profiles.

For an in-depth understanding of the India Adult Vaccine Market, including emerging trends and competitive landscapes, access the full report from Makreo Research.

Similar Related Reports:
India Advanced Wound Care Market Size and Forecast (2018-2028) - Growth Opportunities in the Hydrogel Market
https://www.makreo.com/report/india-wound-care-market-size-forecast-2018-2028-opportunities-hydrogel-market

Makreo Research and Consulting
801, Trishul Goldmine, Palm Beach, Sector 15, Belapur, Navi Mumbai, Maharashtra 400614

Contact us at:
Meetu Bhasin, Director of Research and Operations
Phone Number
+91-9619699069
Email Address
info@makreo.com

Makreo Research is a leading market research and consulting firm based in India, specializing in Syndicated Research, Custom Research, Consulting, and Market Surveys. With expertise in navigating complex market dynamics, we empower businesses to succeed. Our services span a wide range of industries and geographies, including North America, LATAM, Europe, Asia-Pacific, Oceania, MENA, and more.

This release was published on openPR.